Uncategorized

Certain Lots of Taro-Zoledronic acid injection drug, used for osteoporosis and Paget’s disease, recalled due to potential presence of particulate matter

Posted on

Health Canada is advising Canadians that Taro Pharmaceuticals Inc. is recalling five lots of Taro-Zoledronic acid injection 5mg/100mL (DIN 02415100) because of the potential presence of particulate matter in the drug. Zoledronic acid is used to treat and prevent osteoporosis, as well as to treat Paget’s disease (i.e., a condition that causes bone deformities).

Uncategorized

One lot of Atoma-brand Diphenhydramine Hydrochloride 2% Anti-Itch Cream recalled because of a labelling error regarding use in children under two years of age

Posted on

OTTAWA – Health Canada is advising Canadians, particularly parents and caregivers, that Taro Pharmaceuticals Inc. is recalling one lot of Atoma-brand Diphenhydramine Hydrochloride 2% Anti-Itch Cream because of a labelling error that may pose serious health risks to children under two years of age.

Uncategorized

KHN’s ‘What The Health?’: Gun Violence And The Politics Of Public Health

Posted on

The recent tragic mass shootings have refocused efforts to treat gun violence as a public health issue rather than strictly a law enforcement problem. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Mary Agnes Carey of Kaiser Health News join KHN’s Julie Rovner to discuss this, plus the health implications of the budget deal passed by Congress and signed by President Donald Trump, as well as reaction from Canada to a proposal to allow broader imports of its prescription drugs. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.